Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
The addition of bevacizumab to paclitaxel plus carboplatin in the treatment of selected patients with non-small-cell lung cancer has a significant survival benefit with the risk...